Back Talk

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Pharma's role in cost control

Pharma's role in cost control

It may be time to adopt a model in which we help deliver healthcare

Think you own your brand? Think again

Think you own your brand? Think again

When you have a successful brand, you tamper with it at your peril

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Making medicine emotional

Making medicine emotional

We identify not with just the product, but with what it represents

Popping the digital bubble

Popping the digital bubble

A general consensus is that a "shake-up" of some kind is coming

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.

Putting moves on Big Data

Putting moves on Big Data

It's time to make healthcare data Big, and for patients' sake, sexy

Agencies, get over your fear

Agencies, get over your fear

Success cures fear, and success is born out of focus and hard work

From RFP to termination call

From RFP to termination call

There is room for growth, loyalty and long-term partnering

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.